Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines
- 1 January 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 185, 111832
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation
- Fox Chase Cancer Center
This publication has 53 references indexed in Scilit:
- SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-GuérinJournal of Urology, 2013
- Trends in Hospital Volume and Operative Mortality for High-Risk SurgeryNew England Journal of Medicine, 2011
- Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazoleOrganic & Biomolecular Chemistry, 2011
- Effect of Preoperative Nutritional Deficiency on Mortality After Radical Cystectomy for Bladder CancerJournal of Urology, 2011
- A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquidsBioorganic & Medicinal Chemistry Letters, 2010
- Complications and Mortality After Radical Cystectomy for Bladder Transitional Cell CancerJournal of Urology, 2009
- Synthesis and cytotoxic activities of novel phenacylimidazolium bromidesBioorganic & Medicinal Chemistry Letters, 2009
- Imidazole Alkaloids from Lepidium meyeniiJournal of Natural Products, 2003
- Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumorsJournal of Urology, 2002
- Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at DiagnosisMedical Care, 1995